Evidence map›Paper›PMID 35917106›Full record

ArticleAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry2022

Rapid and quantitative detection of multiple antibodies against SARS-CoV-2 mutant proteins by photo-immobilized microarray.

Jun Akimoto, Hiroharu Kashiwagi, Nobuhiro Morishima, Sei Obuse, Takashi Isoshima, Takahiro Kageyama, Hiroshi Nakajima, Yoshihiro Ito

Open access · bronzeAbstract read
In one paragraph

Article in Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Development of practical techniques for simultaneous detection and distinction of current and emerging SARS-CoV-2 variants.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2023
    Review
  2. Recent development of affinity-based assay systems.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2023
    Article
  3. Flower-like WSeAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Jun AkimotoEmergent Bioengineering Materials Research Team, RIKEN Center for Emergent Matter Science, 2-1 Hirosawa, Wako-shi, Saitama, 351-0198, Japan.
Hiroharu KashiwagiEmergent Bioengineering Materials Research Team, RIKEN Center for Emergent Matter Science, 2-1 Hirosawa, Wako-shi, Saitama, 351-0198, Japan.
Nobuhiro MorishimaR-NanoBio Co., Ltd., Wako-RIKEN Incubation Plaza, 3-13 Minami, Wako-shi, Saitama, 351-0104, Japan.
Sei ObuseEmergent Bioengineering Materials Research Team, RIKEN Center for Emergent Matter Science, 2-1 Hirosawa, Wako-shi, Saitama, 351-0198, Japan.
Takashi IsoshimaNano Medical Engineering Laboratory, RIKEN Cluster for Pioneering Research, 2-1 Hirosawa, Wako-shi, Saitama, 351-0198, Japan.
Takahiro KageyamaDepartment of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba City, Chiba, 260-8670, Japan.
Hiroshi NakajimaDepartment of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba City, Chiba, 260-8670, Japan.
Yoshihiro ItoEmergent Bioengineering Materials Research Team, RIKEN Center for Emergent Matter Science, 2-1 Hirosawa, Wako-shi, Saitama, 351-0198, Japan. y-ito@riken.jp.ORCID http://orcid.org/0000-0002-1154-253X
Chiba University · JPPioneer (Japan) · JPRIKEN · JPPioneer (United States) · USRIKEN Center for Emergent Matter Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A rapid automatic quantitative diagnostic system for multiple SARS-CoV-2 mutant protein-specific antibodies was developed using a microarray with photoreactive polymers. Two types of photoreactive polymers, phenylazide and polyoxyethylene, were prepared. The polymers were coated on a plastic plate. Aqueous solutions of mutant virus proteins were microspotted on the coated plate and immobilized by photoirradiation. Virus-specific IgG in the serum or blood was automatically assayed using an instrument that we developed for pipetting, reagent stirring, and washing. The results highly correlated with those of the conventional enzyme-linked immunoassay or immunochromatography. This system was successfully used to test the sera or blood from the patients recovered from the infection and the vaccinated individuals. The recovered individuals had antibodies against the nucleoprotein, in contrast to the vaccinated individuals. The amount of antibodies produced decreased with an increase in virus mutation. Blood collected from the fingertip (5 μL) and a test period of 8 min were sufficient conditions for conducting multiple antibody assays. We believe that our system would facilitate rapid and quantitative automatic assays and aid in the diagnosis of various viral infectious diseases and assessment of the immune status for clinical applications.

Indexed as

COVID-19SARS-CoV-2Antibodies, ViralHumansImmunoglobulin GMutant ProteinsNucleoproteinsPlasticsPolyethylene GlycolsPolymersSensitivity and SpecificityAntibodies, ViralImmunoglobulin GMutant ProteinsNucleoproteinsPlasticsPolyethylene GlycolsPolymersAntibody detectionBlood testCOVID-19Microarray

Identifiers

PMID35917106
PMCPMC9343572
OpenAlexW4289519815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.